» » Apalutamide Significantly Improved Metastasis-Free Survival in Men With nmCRPC
Edit

Apalutamide Significantly Improved Metastasis-Free Survival in Men With nmCRPC

Apalutamide Significantly Improved Metastasis-Free Survival in Men With nmCRPC
  1. Apalutamide Significantly Improved Metastasis-Free Survival in Men With nmCRPC  AJMC.com Managed Markets Network
  2. Apalutamide delays progression of nonmetastatic, castration-resistant prostate cancer  EurekAlert (press release)
  3. ASCO GU 2018: Review of First Presentation: SPARTAN and PROSPER  UroTodayFull coverage

Read More ...
Apalutamide Significantly Improved Metastasis-Free Survival in Men With nmCRPC published February 09, 2018 at 09:15AM. Original Source Link : http://www.ajmc.com/conferences/gu-symposium-2018/apalutamide-significantly-improved-metastasisfree-survival-in-men-with-nmcrpc
loading...

0 Response to "Apalutamide Significantly Improved Metastasis-Free Survival in Men With nmCRPC"

Posting Komentar

Langganan: Posting Komentar (Atom)